{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:36:01Z","timestamp":1758638161825},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.numecd.2007.03.010","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T18:06:13Z","timestamp":1196186773000},"page":"342-348","source":"Crossref","is-referenced-by-count":21,"title":["Orlistat and sibutramine beyond weight loss"],"prefix":"10.1016","volume":"18","author":[{"given":"Edoardo","family":"Mannucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Dicembrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Rotella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Maria","family":"Rotella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2007.03.010_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7326\/0003-4819-138-1-200301070-00008","article-title":"Obesity in adulthood and its consequences for life expectancy: a life-table analysis","volume":"138","author":"Peeters","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2007.03.010_bib2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/archinte.147.10.1749","article-title":"Long-term effects of modest weight loss in type II diabetic patients","volume":"147","author":"Wing","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.numecd.2007.03.010_bib3","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1210\/jc.77.5.1287","article-title":"Relative effects of caloric restrictions and weight loss in non insulin-dependent diabetes mellitus","volume":"77","author":"Kelly","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2007.03.010_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.HYP.36.1.20","article-title":"Differentiated long-term effects of intentional weight loss on diabetes and hypertension","volume":"36","author":"Sjostrom","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2007.03.010_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archinte.157.6.657","article-title":"Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal pressure: the trials of hypertension prevention, phase II","volume":"157","author":"The Trials of Hypertension Prevention collaborative Research Group","year":"1997","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.numecd.2007.03.010_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/oby.2000.32","article-title":"Overweight, obesity, and blood pressure: the effects of modest weight reduction","volume":"8","author":"Martens","year":"2000","journal-title":"Obes Res"},{"issue":"11","key":"10.1016\/j.numecd.2007.03.010_bib7","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/archinte.165.11.1298","article-title":"Weight loss in overweight adults and the long-term risk of hypertension: the Framingham Study","volume":"165","author":"Moore","year":"2005","journal-title":"Arch Intern Med"},{"issue":"suppl. 2","key":"10.1016\/j.numecd.2007.03.010_bib8","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report","volume":"6","author":"National Institutes of Health, National Heart, Lung and Blood Institute","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.numecd.2007.03.010_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/ajcn\/56.2.320","article-title":"Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis","volume":"56","author":"Dattilo","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2007.03.010_bib10","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/ajcn\/80.6.1461","article-title":"Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials","volume":"80","author":"Hutton","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2007.03.010_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-277X.2004.00530.x","article-title":"What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions","volume":"17","author":"Avenell","year":"2004","journal-title":"J\u00a0Hum Nutr Dietet"},{"issue":"1","key":"10.1016\/j.numecd.2007.03.010_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clin Trials"},{"key":"10.1016\/j.numecd.2007.03.010_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1463-1326.2002.00237.x","article-title":"The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial","volume":"4","author":"Hanefeld","year":"2002","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.numecd.2007.03.010_bib14","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2337\/diacare.25.6.1033","article-title":"Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes","volume":"25","author":"Kelley","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2007.03.010_bib15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2337\/diacare.25.7.1123","article-title":"Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin","volume":"25","author":"Miles","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2007.03.010_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0002-9149(03)00112-7","article-title":"Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia","volume":"91","author":"Lucas","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2007.03.010_bib17","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0149-2918(03)80070-X","article-title":"Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both, on anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed as a standardized diet","volume":"25","author":"Derosa","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.numecd.2007.03.010_bib18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2036.2004.01966.x","article-title":"Cholesterol lowering effect of dietary weight loss and orlistat treatment -efficacy and limitations","volume":"19","author":"Erdmann","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.numecd.2007.03.010_bib19","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.ijo.0801814","article-title":"The effect of orlistat on weight and serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study","volume":"25","author":"Muls","year":"2001","journal-title":"Int J Obes"},{"key":"10.1016\/j.numecd.2007.03.010_bib20","first-page":"460","article-title":"The role of orlistat in the treatment of obese patients with mild to moderate hypercholesterolemia: consequences for coronary risk","volume":"9","author":"Broom","year":"2002","journal-title":"Br J Cardiol"},{"key":"10.1016\/j.numecd.2007.03.010_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/oby.2000.8","article-title":"Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity","volume":"8","author":"Rossner","year":"2000","journal-title":"Obes Res"},{"key":"10.1016\/j.numecd.2007.03.010_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-2796.2000.00720.x","article-title":"The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish multimorbidity study","volume":"248","author":"Lindgarde","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2007.03.010_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"Xenical in the prevention of diabetes in obese subjects (XENDOS) study","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2007.03.010_bib24","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/00004872-199816121-00024","article-title":"Treatment with orlistat reduces cardiovascular risk in obese patients","volume":"16","author":"Zavoral","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2007.03.010_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients","volume":"352","author":"Sjostrom","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2007.03.010_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/archfami.9.2.160","article-title":"Orlistat in long-term treatment of obesity in primary care settings","volume":"9","author":"Hauptman","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.numecd.2007.03.010_bib27","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/ajcn\/69.6.1108","article-title":"Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study","volume":"69","author":"Hill","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2007.03.010_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1464-5491.2002.00655.x","article-title":"Role of sibutramine in the treatment of obese type 2 diabetic patients receiving sulphonylurea therapy","volume":"19","author":"Serrano-Rios","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.numecd.2007.03.010_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/diacare.26.1.125","article-title":"A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin","volume":"26","author":"McNulty","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2007.03.010_bib30","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.clinthera.2004.09.017","article-title":"Use of sibutramine in overweight Hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial","volume":"26","author":"Sanchez-Reyes","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.numecd.2007.03.010_bib31","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2337\/diacare.24.11.1957","article-title":"Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control","volume":"24","author":"Gokcel","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2007.03.010_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1463-1326.2000.00081.x","article-title":"Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus","volume":"2","author":"Fujioka","year":"2000","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.numecd.2007.03.010_bib33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1067\/mhj.2001.117510","article-title":"Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and\u00a0obese patients with dyslipidemia","volume":"142","author":"Dujovne","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2007.03.010_bib34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1463-1326.2005.00465.x","article-title":"Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients","volume":"7","author":"Faria","year":"2004","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.numecd.2007.03.010_bib35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1590\/S0041-87812002000300003","article-title":"Evaluation of efficacy, reliability, and tolerability of sibutramine in obese patients, with an echocardiographic study","volume":"57","author":"Halpern","year":"2002","journal-title":"Rev Hosp Clin Fac Med S Paulo"},{"key":"10.1016\/j.numecd.2007.03.010_bib36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1463-1326.2003.00285.x","article-title":"Sibutramine enhances insulin sensitivity ameliorating metabolic parameters in a double-blind, randomized, placebo-controlled trial","volume":"5","author":"Tambascia","year":"2003","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.numecd.2007.03.010_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","article-title":"Sibutramine produces dose-related weight loss","volume":"2","author":"Bray","year":"1999","journal-title":"Obes Res"},{"key":"10.1016\/j.numecd.2007.03.010_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.numecd.2004.07.002","article-title":"Effects of Sibutramine-induced weight loss on cardiovascular system in obese subjects","volume":"15","author":"De Simone","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.numecd.2007.03.010_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.arcmed.2005.01.005","article-title":"Regulation of triglycerides in insulin resistance and diabetes","volume":"36","author":"Ginsberg","year":"2005","journal-title":"Arch Med Res"},{"key":"10.1016\/j.numecd.2007.03.010_bib40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.ejcn.1601235","article-title":"Short-term changes of cardiovascular risk factors after non-pharmacological body weight reduction program","volume":"55","author":"Sartorio","year":"2001","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.numecd.2007.03.010_bib41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"1-2","key":"10.1016\/j.numecd.2007.03.010_bib42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cca.2005.08.026","article-title":"Calculated low density cholesterol levels frequently underestimate directly measured low density lipoprotein cholesterol determinations in patients with serum triglyceride levels \u22644.52 mmol\/l: an\u00a0analysis comparing the LipiDirect magnetic LDL assay with Friedewald calculation","volume":"365","author":"Tighe","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"10","key":"10.1016\/j.numecd.2007.03.010_bib43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/oby.2001.79","article-title":"Orlistat inhibits dietary cholesterol absorption","volume":"9","author":"Mittendorfer","year":"2001","journal-title":"Obes Res"},{"key":"10.1016\/j.numecd.2007.03.010_bib44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1381\/0960892053576839","article-title":"Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity","volume":"11","author":"Corradini","year":"2005","journal-title":"Obes Surg"},{"key":"10.1016\/j.numecd.2007.03.010_bib45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-142-7-200504050-00011","article-title":"Pharmacologic and surgical management of obesity in Primary Care: a clinical practice guideline from American College of Physicians","volume":"142","author":"Snow","year":"2005","journal-title":"Ann Intern Med"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475307000786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475307000786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T21:56:13Z","timestamp":1588110973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475307000786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0939475307000786"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2007.03.010","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}